Compounds > fludarabine

fludarabine and Glomerulonephritis, Membranous

fludarabine has been researched along with Glomerulonephritis, Membranous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haller, NA; Lee, B; Novak, R; Robertson, S; Smith, RS; Tanphaichitr, N1
Giannakakis, C; Guido, G; Mosillo, G; Rocca, AR; Salviani, C; Serriello, I1
Asfoura, J; Butty, H; Cortese, F; Doyle, M; Rutecki, G1
Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E1
Abdel-Raheem, MM; Gross, GG; Jamil, MG; Potti, A1

Reviews

1 review(s) available for fludarabine and Glomerulonephritis, Membranous

ArticleYear
Fludarabine in chronic lymphocytic leukemia with membranous nephropathy.
    Renal failure, 2013, Volume: 35, Issue:2

    Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Proteinuria; Rare Diseases; Risk Assessment; Treatment Outcome; Vidarabine

2013

Other Studies

4 other study(ies) available for fludarabine and Glomerulonephritis, Membranous

ArticleYear
Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
    Scandinavian journal of urology and nephrology, 2011, Volume: 45, Issue:6

    Topics: Adult; Angiotensin Receptor Antagonists; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Glomerulonephritis, Membranous; Humans; Immunoglobulin lambda-Chains; Immunoglobulin M; Male; Nephrotic Syndrome; Rituximab; Vidarabine; Waldenstrom Macroglobulinemia

2011
Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 33, Issue:2

    Topics: Antineoplastic Agents; Biopsy; Female; Glomerulonephritis, Membranous; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine

1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Clinical nephrology, 1999, Volume: 52, Issue:2

    Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine

1999
Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Haematologica, 2000, Volume: 85, Issue:11

    Topics: Antineoplastic Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranous; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome; Proteinuria; Remission Induction; Treatment Outcome; Vidarabine

2000